Articles published by Gilead Sciences, Inc.
Gilead Sciences to Present at Upcoming Investor Engagements
November 08, 2024
Via Business Wire
Tickers
GILD
Gilead Sciences Announces Third Quarter 2024 Financial Results
November 06, 2024
Via Business Wire
Tickers
GILD
Gilead Sciences to Release Third Quarter 2024 Financial Results on Wednesday, November 6, 2024
October 09, 2024
Via Business Wire
Tickers
GILD
Gilead and Genesis Therapeutics Announce Strategic Collaboration to Discover and Develop Novel Therapies
September 10, 2024
Via Business Wire
Tickers
GILD
Gilead to Present New Trodelvy® Data at the IASLC 2024 World Conference on Lung Cancer
September 05, 2024
Via Business Wire
Tickers
GILD
Gilead Sciences to Present at Upcoming Investor Conferences
August 21, 2024
Via Business Wire
Tickers
GILD
Gilead’s Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by U.S. FDA
August 14, 2024
Via Business Wire
Tickers
GILD
Gilead Sciences Announces Second Quarter 2024 Financial Results
August 08, 2024
Via Business Wire
Tickers
GILD
Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 25, 2024
Via Business Wire
Tickers
GILD
Via Business Wire
Tickers
GILD
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.